Bladder Cancer Trial, Recruiting NCT06763354 Sponsor: RenJi Hospital Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06763354
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part and have signed a consent form agreeing to join the study
  • You are between 19 and 84 years old
  • You have been diagnosed with a bladder tumour through a camera examination of the bladder (a procedure called a cystoscopy), and you do not necessarily need to have had scans or tissue test results
  • You are willing and able to follow all the requirements of the trial as instructed

Who may not be able to join:

  • You are pregnant, currently breastfeeding, or are under 18 years old
  • You have serious liver or kidney problems (confirm with trial site)
  • You have a known sensitivity or allergic reaction to the study drug, or you have a history of allergies to multiple medications

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86 13512116782

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
8 February 2025
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Tumor specific lighting ability of Gallium[68Ga]NOTA-DNA Multivalent SGC8

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov